Recall of Three Lots of Pfizer Inc Drug, Effexor
Three lots of sixth most popular antidepressant drug in the US market, Effexor, have been recalled by the drug maker Pfizer following report that another drug Tikosyn was found in the package of Effexor. All the pharmacists have been asked by the company and the U. S. Food and Drug Administration (FDA) to return all the recalled lots.
Some samples of the drug, Tikosyn, were found by a pharmacist in the bottle of the Effexor XR, the combination of which could prove fatal in certain cases for patients of depression.
Also, one lot of venlafaxine HCI 150 mg extended release capsules of the generic Greenstone grand LLC Company with 90-count bottles of the branded drug has been recalled. The total of three lots of the Effexor includes about 104,450 bottles of medicines, out of which 65,800 were received by the pharmacies in the country.
The Tikosyn drug is basically used for treating atrial fibrillation, a heart disease with common and potentially dangerous irregular heartbeat. According to the company, serious side-effects are associated with intake of Tikosyn which can leads to death in some cases.
The generic versions of the drugs made by other manufacturers will not get affected with the recall issued by Pfizer. Patients have been advised by the FDA to immediately contact doctors and diagnose themselves for signs of an abnormal heartbeat if they had consumed the drug.
Pfizer has not received any consumer complaints so far.